Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue

British Journal of Cancer

Volumn 78, Issue 12, 1998, Pages 1573-1577

  Saito, H ^a   Tsujitani, S ^a   Ikeguchi, M ^a   Maeta, M ^a   Kaibara, N ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Gastric cancer; S 100 protein; Vascular endothelial growth factor

Indexed keywords

CD34 ANTIGEN; PROTEIN S 100; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INFILTRATION; CANCER SURGERY; CANCER SURVIVAL; CELL DENSITY; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL; STOMACH ADENOCARCINOMA; SURVIVAL TIME; TUMOR GROWTH;

EID: 0031738664     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.725     Document Type: Article

References (22)

1. Ambe K, Mori K and Enjoji M (1989) S-100 protein-positive dendritic cells in colorectal adenocarcinomas: distribution and relation to the clinical prognosis. Cancer 63: 496-503
2. Fontanini G, Vignati S, Boldrini L, Chiné S, Silvestri V, Lucchi M, Mussi A, Angeletti CA and Bevilacqua G (1997) Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 3: 861-865
3. Furukawa T, Watanabe S, Sato Y, Kodama T, Nakajima T and Shimosato Y (1984) Heterogeneity of histiocytes in primary lung cancer stained with anti-S100 protein, lysozyme and OKT 6 antibodies. Jpn J Clin Oncol 14: 647-658
4. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D and Carbone DP (1996a) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 2: 1096-1103
5. Gabrilovich DJ, Nadaf S, Corak J, Berzofsky JA and Carbone DP (1996b) Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell Immunol 170: 111-120
6. Inoue K, Ozeki Y, Suganuma T, Sugiura Y and Tanaka S (1997) Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer 79: 206-213
7. Japanese Research Society for Gastric Cancer (1995) Japanese Classification of Gastric Carcinoma. Kanehara, Tokyo
8. Kakeji Y, Maehara Y, Korenaga D, Tsujitani S, Haraguchi M, Watanabe A, Orita H and Sugimachi K (1993) Prognostic significance of tumor-host interaction in clinical gastric cancer: relationship between DNA ploidy and dendritic cell infiltration. J Surg Oncol 52: 207-212
9. Katoh O, Tauchi H, Kawaishi K, Kimura A and Satow Y (1995) Epression of the vascular endothelial growth factor (VEGF) receptor gene. KDR. in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55: 5687-5692
10. Kekow J and Wiedemann GJ (1995) Transforming growth factor β: a cytokine with multiple actions in oncology and potential clinical applications. Int J Oncol 7: 177-182
11. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863
12. Maehara Y, Tomisaki S, Oda S, Kakeji Y, Tsujitani S, Ichiyoshi Y, Akazawa K and Sugimachi K (1997) Lymph node metastasis and relation to tumour growth potential and local immune response in advanced gastric cancer. Int J Cancer 74: 224-228
13. Matsuda H, Mori M, Tsujitani S, Ohno S, Kuwano H and Sugimachi K (1990) Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissue. Cancer 65: 2261-2265
14. Miyake M, Taki T, Hitomi S and Hakomori S (1992) Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med 327: 14-18
15. Nakano T, Oka K, Arai T, Morita S and Tsunemoto H (1989) Prognostic significance of Langerhans' cell infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med 113: 507-511
16. Nomori H, Watanabe S, Kaneya T, Nakajima T, Shimosato Y and Kameya T (1986) Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 57: 100-105
17. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Mosesm M, Lane WS, Cao Y, Sage EH and Folkman J (1994) Angiostain: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328
18. Toi M, Hoshina S, Takayanagi T and Tominaga T (1994) Association of vascular endothelial growth factor expression with tumor angiogenesis and with early response in primary breast cancer. Jpn J Cancer Res 85: 1045-1049
19. Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y and Sugimachi K (1990) Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 66: 2012-2016
20. Tsujitani S, Furukawa T, Tamada R, Okamura T, Yasumoto K and Sugimachi K (1987) Langerhans' cells and prognosis in patients with gastric carcinoma. Cancer 59: 501-505
21. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K and FujitaT (1993) Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(choroacetyl-carhamoyl) fumagillol (TNP-470: AGM-1470). Cancer Res 53: 4262-4267
22. Yanase T, Tamura M, Fujita K, Kodama S and Tanaka K (1993) Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53: 2566-2570